Tepoditamab [2044679-53-8]

TargetMol Chemicals

Tepoditamab

9

2044679-53-8

Antibody

Research Use Only

Tepoditamab

Tepoditamab (MCLA-117) is a bispecific monoclonal antibody targeting CLEC12A on myeloid cells and CD3 on cytotoxic T cells. As a myeloid differentiation antigen, CLEC12A allows the compound to eliminate AML leukemia progenitor and stem cells through T cell-mediated proliferative lysis, making it valuable in acute myeloid leukemia (AML) research [1].

3 years

-20°C

12352203